Binding of KB-1980E6.3, in turn, enhances the recognition of m6A-modified c-Myc mRNA by IGF2BP1, and hence the stability of c-Myc mRNA, thus triggering a cascade of oncogenic events, resulting in breast cancer cell stemness and tumorigenesis, both in vitro and in vivo. Here, IGF2BP1 is linked to breast cancer.